Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease
BackgroundCachexia is associated with poor prognosis in chronic liver disease (CLD), yet robust predictors remain poorly defined. This study examined clinical factors and serum biomarkers associated with cachexia in patients with CLD.MethodsWe analyzed 356 of 526 patients with CLD who had complete c...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Frontiers Media S.A.
2026-02-01
|
| سلاسل: | Frontiers in Nutrition |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.frontiersin.org/articles/10.3389/fnut.2026.1730695/full |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|